Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bowling Claims Administration (BCA) was a specialized entity established to manage and process claims resulting from the Bowling v. Pfizer class-action settlement. The litigation concerned the Bjork-Shiley Convexo-Concave (BSCC) heart valve, a medical device manufactured by Shiley, a subsidiary of Pfizer, which was found to have a risk of mechanical failure. BCA was responsible for identifying eligible claimants, evaluating medical records, and distributing settlement funds for valve fractures and prophylactic replacements. The organization operated under the supervision of the United States District Court for the Southern District of Ohio and played a critical role in one of the most significant medical device product liability settlements in history. Its primary function was to ensure that affected patients received compensation and medical monitoring as mandated by the court-approved settlement agreement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bowling Claims Administration.